I.V Papavrine for Labor Induction in Term PROM

Summary

This prospective randomized controlled trial aims to evaluate whether intravenous administration of papaverine 12 hours after term PROM reduces the interval from membrane rupture to delivery and improves maternal and neonatal outcomes. Researchers will compare drug papaverine to a placebo

Timeline

Start

2025-10-22

Primary completion

2027-10-22

Completion

2027-10-22

Drugs

Indications